YHB Investment Advisors Inc. cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 4.2% in the 1st quarter, Holdings Channel reports. The institutional investor owned 29,699 shares of the healthcare conglomerate’s stock after selling 1,303 shares during the quarter. UnitedHealth Group makes up 1.3% of YHB Investment Advisors Inc.’s holdings, making the stock its 17th biggest holding. YHB Investment Advisors Inc.’s holdings in UnitedHealth Group were worth $15,555,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at about $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new position in UnitedHealth Group during the fourth quarter valued at approximately $26,000. Hurley Capital LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $28,000. Aster Capital Management DIFC Ltd purchased a new stake in UnitedHealth Group during the 4th quarter worth $30,000. Finally, Promus Capital LLC purchased a new position in UnitedHealth Group in the fourth quarter valued at about $32,000. Institutional investors and hedge funds own 87.86% of the company’s stock.
Insider Activity
In related news, Director Timothy Patrick Flynn acquired 1,533 shares of the business’s stock in a transaction that occurred on Wednesday, May 14th. The shares were acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the purchase, the director now directly owns 6,033 shares in the company, valued at $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Stephen J. Hemsley bought 86,700 shares of the firm’s stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the transaction, the chief executive officer now directly owns 679,493 shares in the company, valued at $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders have acquired 109,408 shares of company stock valued at $31,607,768. Insiders own 0.28% of the company’s stock.
UnitedHealth Group Price Performance
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter in the prior year, the firm earned $6.91 EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be given a $2.21 dividend. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 2.94%. UnitedHealth Group’s dividend payout ratio is 37.02%.
Analyst Ratings Changes
Several equities research analysts recently commented on UNH shares. KeyCorp dropped their target price on UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating on the stock in a report on Monday, June 2nd. Wall Street Zen cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Saturday, May 24th. Bank of America downgraded shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $560.00 to $350.00 in a research note on Wednesday, May 14th. Baird R W downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, June 11th. Finally, JPMorgan Chase & Co. increased their price target on UnitedHealth Group from $405.00 to $418.00 and gave the company an “overweight” rating in a report on Friday. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have given a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $427.09.
View Our Latest Stock Report on UNH
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- The 3 Best Retail Stocks to Shop for in August
- Microsoft Stock Holds Steady as AI Drives Workforce Shift
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- D-Wave Goes International With South Korea Partnership
- What is the MACD Indicator and How to Use it in Your Trading
- Payment Giants Slide on Stablecoin Buzz—Is Now the Time to Buy?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.